B cell alterations during BAFF inhibition with belimumab in SLE

Published: 29 December 2018| Version 1 | DOI: 10.17632/7894wb6yxh.1
Daniel Ramsköld,
Ioannis Parodis,
Lakshmikanth Tadepally,
Natalie Sippl,
Yang Chen,
Agneta Zickert,
Jaromír Mikeš,
Adnane Achour,
khaled amara,
Petter Brodin,
Iva Gunnarsson,
Vivianne Malmström


Mass cytometry data, systemic lupus erythematosus patients at Karolinska Universitetssjukhuset at the start of belimumab treatment and follow-up time-points. Generated on a CyTOF2 machine. In run1, B cells were gated for CD20 (positive) and CD3 (negative) and CD4 T cells for CD20 (negative), CD3 (positive) and CD4 (positive). The data for both runs has been bead normalised.